Brief: Relief Therapeutics And Acer Therapeutics Announce FDA Acceptance For Filing Of New Drug Application

MindMaze Therapeutics Holding SA

06/10/2021 06:06

Oct 6 (Reuters) - RELIEF THERAPEUTICS HOLDING SA  RLFB.S :
    * ACER THERAPEUTICS AND RELIEF THERAPEUTICS ANNOUNCE FDA
ACCEPTANCE FOR FILING OF NEW DRUG APPLICATION FOR ACER-001 TO
TREAT UREA CYCLE DISORDERS
    * FDA HAS ASSIGNED A PRESCRIPTION DRUG USER FEE ACT (PDUFA)
TARGET
ACTION DATE OF JUNE 5, 2022

Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))